Preclinical Study
Also known as: animal study · in vivo / in vitro research
Research conducted in cell cultures (in vitro) or animal models (in vivo) prior to any human testing.
Preclinical studies establish mechanism of action, toxicology, and initial efficacy signals before a compound advances to human trials. They're essential but have well-known translation limitations — a large fraction of rodent efficacy results fail to replicate in humans. This is why preclinical-only evidence warrants cautious protocol design rather than confident application.
Many research peptides live permanently in the preclinical evidence tier. The fact that a compound is 'well-studied in rats' is meaningfully different from 'well-studied in humans' — and protocol decisions should reflect that gap.
Related Terms
Clinical Trial
A prospective research study testing a compound in human subjects under controlled protocol, typically organized into Phase 1 through Phase 4.
Mechanistic Study
Research investigating the molecular and cellular pathways through which a compound produces its effects.
Three-Lane Evidence System
DoseCraft's framework categorizing every compound across three independent evidence dimensions: Clinical, Expert, and Experimental.
Anecdotal Report
An uncontrolled, self-reported account of individual experience with a compound, without systematic data collection or control conditions.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial